Search
for
Sort by
Research 31–60 of 304
- Janus kinase inhibitors for alopecia areata
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Baricitinib for the Treatment of Alopecia Areata
- Ritlecitinib: First Approval
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- pH-Responsive Nanogels from Bioinspired Comb-like Polymers with Hydrophobic Grafts for Effective Oral Delivery
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Involvement of the central hypothalamic-pituitary-adrenal axis in hair growth and melanogenesis among different mouse strains
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Alopecia Areata: Current and Emerging Therapies
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Therapeutic Potential of Nerve Growth Factor-Modified Hair Follicle Stem Cells Transplantation in a Rat Model of Alzheimer’s Disease
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Hair Disorders in Autoimmune Diseases
- Janus kinase inhibitors for alopecia areata: A narrative review
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East